Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

Half-year Report

16 Aug 2022 07:00

RNS Number : 0867W
Nostrum Oil & Gas PLC
16 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

 

London, 16 August 2022

 

 

Financial Results for the second quarter and six months ended 30 June 2022

 

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum", or the "Company" and together with its subsidiaries, the "Group"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, today announces its financial results in respect of the second quarter and six months ended 30 June 2022.

 

Nostrum's management team will present the H1 2022 Results and will be available for a Q&A session with analysts and investors today, 16 August 2022, at 2pm UK time. If you would like to participate in this call, please register by clicking on the following link and following instructions: Results Call

 

H1 2022 Highlights:

 

Financial

· Revenues of US$107.8m (H1 2021: US$92.3m) against average realised Brent oil price of US$104.7/bbl (H1 2021: US$65.2/bbl).

 

· EBITDA1 of US$68.8m (H1 2021: US$52.8m) with EBITDA1 margin of 63.8% (H1 2021: 57.2%).

 

· Closing unrestricted cash as at 30 June 2022 of US$208.7m (31 March 2021: US$180.8m). US$22.7m remains held in a restricted account as at 30 June 2022.

 

· Continued focus on cost optimisation to help manage our liquidity. Targeting US$45.5m for operating and general & administrative expenses for FY2022.

 

Operational

· Daily production after treatment averaged 14,167 boepd (H1 2021: 18,107 boepd).

 

· Daily sales volumes for averaged 13,102 boepd (H1 2021: 16,249 boepd).

 

· The Group continues its well and reservoir management strategy through well workovers and rigless well intervention in 2022.

 

· The Group has initiated a tie back project, budgeted for c.US$5m of capital expenditures, that will allow for the first third-party feedstock from Ural Oil & Gas LLP ("Ural OG") to be received for processing in the Group's facilities by Q4 2023.

 

· The Directors have ensured the Group has remained in full compliance with the Russian sanctions.

 

Sustainability

· Zero fatalities during operations to employees and contractors (H1 2021: zero).

 

· Zero Lost Time Injury ("LTI") (H1 2021: zero).

 

· 2 Total Recordable Incidents ("TRI") (H1 2021: 2).

 

· 81% of staff vaccinated against COVID-19 as at 30 June 2022.

 

· Initiated an ESG task force who will endeavour to receive the first solicited rating from an internationally recognized rating agency.

 

Restructuring update:

· On 20 June 2022, a Scheme Convening hearing was held and the Court made an order granting the Company permission to convene the Scheme meeting.

 

· On 1 July 2022, the Company received the necessary consents from the Kazakhstan Ministry of Energy with respect to (i) the issuance of new shares and warrants and (ii) the waiver of the Republic of Kazakhstan's priority right to acquire these new shares and warrants. This is a condition to the successful closing of the restructuring.

 

· The Scheme meeting of creditors will take place next week on 22 August 2022. The restructuring will be implemented as soon as practicable following a planned court sanction hearing (currently scheduled after the Scheme meeting) and following the receipt of all necessary authorisations and licenses to complete the transaction. The Company anticipates receiving all necessary authorisations and licences required to close before or at the start of Q4.

 

Sales volumesThe sales volume split for H1 2022 was as follows:

Products

H1 2022 volumes

(boepd)

H1 2022

product mix

 (%)

H1 2021 volumes

(boepd)

H1 2021

product mix

 (%)

Crude Oil

2,858

21.8%

3,705

22.8%

Stabilised Condensate

3,100

23.7%

3,170

19.5%

LPG (Liquid Petroleum Gas)

1,836

14.0%

2,150

13.2%

Dry Gas

5,308

40.5%

7,224

44.5%

Total

13,102

100.0%

16,249

100.0%

 

The difference between production and sales volumes is primarily due to the internal consumption of gas and the timing of selling condensate.

 

Arfan Khan, Chief Executive Officer of Nostrum Oil & Gas, commented:

"As always, working in a safe and sustainable way is a key priority for the Group and I am pleased we had no major safety incidents in the first half of the year. We made our Carbon Disclosure Project (CDP) submissions recently and have tasked an external party to perform an ESG review of the Group. This underpins our commitment to sustainability as we look to improve the way we operate.

 

We are now at the final stages of the restructuring and hope to complete all remaining steps by the end of Q3 / start of Q4. This has been a long road, but we are ready to pivot the Company towards growth under our new streamlined capital structure. Our core financial business continues to remain strong despite the natural decline in production - as shown by our half year results. We generated revenues of over US$107m, EBITDA of c.$69m and maintained a healthy EBITDA margin of 63.8%. We've managed to market our products as effectively as possible with high Brent and LPG prices as well as maintain strong costs discipline to ensure our cash position continues to grow. Ending the period with over US$208m provides us with a solid base to execute some of our strategic initiatives lined up for a post restructured world.

 

We are doing a lot of work to identify and mature various growth initiatives that will help fill our gas treatment facilities, and we hope to be able to progress a number of these post the restructuring."

 

 

The Company's results materials are available to download on Nostrum's website:

 

Download: H1 2022 Results Presentation

Download: H1 2022 Interim Financial Report

 

Notes to press release

1 EBITDA is defined as profit before tax net of finance costs, impairment, foreign exchange loss/gain, ESOP, depreciation, interest income, other income and expenses.

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nog.co.uk

 

Further enquiries

Shane Drader - Chief Financial Officer

ir@nog.co.uk

 

Instinctif Partners - UK

Tim McCall

Galyna Kulachek

Sarah Hourahane

+ 44 (0) 207 457 2020

nostrum@instinctif.com

 

Notifying person

Thomas Hartnett

Company Secretary

 

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG) and the Kazakhstan Stock Exchange (ticker symbol: GB_NTRM). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field that is being operated by a wholly-owned subsidiary of Nostrum Oil & Gas PLC - Zhaikmunai LLP, who is the sole holder of the subsoil use rights with respect to the development of the field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

 

Appendix

 

Key terms of the restructuring

 

The agreed terms which will proceed under a UK scheme of arrangement subject to the creditors' vote and Court sanction, are as follows:

 

1. Partial reinstatement of the Existing Notes in the form of new:

 

a) Senior Secured Notes ("SSNs")

· Principal amount of US$250,000,000; 

· Cash coupon of 5.00% per annum;

· Interest accrues from 1 January 2022;

· Maturing on 30 June 2026; and

· SSNs are not convertible upon maturity.

 

b) Senior Unsecured Notes ("SSNs")

· Principal amount of US$300,000,000; 

· Cash coupon of 1.00% per annum;

· Payment-in-kind interest of 13.00% per annum;

· Interest accrues from 1 January 2022;

· Maturing on 30 June 2026; and

· If not repaid in cash at maturity, the SUNs will be repayable in specie through the issuance of equity of the Company based on the value of the SUNs outstanding on the issuance date as a percentage of the fair market value of the Company (up to a maximum of 99.99% of the Company's fully diluted equity).

 

2. Conversion of the remainder of the Existing Notes and accrued interest into equity by way of a UK scheme of arrangement:

 

· Existing noteholders will own 88.89% of the expanded share capital of the Company on closing of the restructuring.

· Existing noteholders will also own warrants (to be held by a Trustee) allowing them to subscribe for an additional 1.11% of the share capital of the Company upon exercise - increasing existing noteholder ownership of the Company to 90.00% on closing.

 

3. New corporate governance arrangements in respect of the Group and certain arrangements regarding future utilisation of the Group's cashflows, including the proposal to transfer the Company's listing to the Standard Listing segment of the London Stock Exchange (this became effective on 31 May 2022).

 

For material terms of the restructuring, refer to the Regulatory News Service ("RNS") announcement issued on 23 December 2021 and the restructuring Circular issued to shareholders on 13 April 2022 which can be found on our website.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SFLFMIEESELA
Date   Source Headline
1st Jun 20267:00 amRNSPublication of Annual Report and Notice of AGM
26th May 20267:09 amRNS1st Quarter Results
14th May 202610:59 amRNSUpdate re Kazakhstan withholding tax disputes
7th May 20265:11 pmRNSBoard Change
30th Apr 20267:00 amRNSOperational Update for Q1 ended 31 March 2026
29th Apr 20267:00 amRNSFull Year Results
30th Mar 202611:38 amRNSProposed Transaction
17th Feb 202611:51 amRNSFurther update on Kazakhstan withholding tax
9th Feb 20269:17 amRNS-RUpdate re Kazakhstan withholding tax disputes
9th Feb 20267:00 amRNSBoard Committee Changes
3rd Feb 20269:38 amRNS-RUpdate on Kazakhstan withholding tax disputes
30th Jan 20267:00 amRNSOperational Update for Q4 and FY2025
26th Jan 202612:18 pmRNSBoard Change
2nd Jan 20268:30 amRNSNotice of delayed interest payments on notes
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
19th Dec 20255:02 pmRNSFurther statement in relation to AGM vote
25th Nov 20257:00 amRNSFinancial results for Q3 and 9M 2025
21st Nov 20257:00 amRNSAppointment of NED and Board Committee Changes
31st Oct 202511:27 amRNSBoard Committee Change
31st Oct 20257:00 amRNSOperational Update for 3Q and 9M 2025
24th Oct 20257:00 amRNSAppointment of a NED and Board Committee Changes
17th Oct 20257:00 amRNSAppointment of Nikolay Ivin as Chairman
6th Oct 202510:57 amRNSConsent Solicitation Results
24th Sep 202510:02 amRNSConsent Solicitation
19th Sep 202512:38 pmRNSNew CFO
16th Sep 20254:35 pmRNSConsent solicitation results at early consent date
16th Sep 20253:40 pmRNSMaterial related party transaction and new COO
2nd Sep 20255:23 pmRNSConsent solicitation re payment delay on notes
29th Aug 20257:00 amRNSFinancial results for Q2 and 6M ended 30 June 2025
31st Jul 20257:00 amRNSOperational Update for Q2 and H1 2025
30th Jul 20259:19 amRNSUpdate: delayed interest payments,proposed actions
22nd Jul 20253:33 pmRNSUpdate: delayed interest payments,proposed actions
15th Jul 20255:37 pmRNSAppointment of CEO and a Non-Executive Director
10th Jul 202511:38 amRNSNotification of delayed interest payments
30th Jun 20251:48 pmRNSStakeholder discussions and Board changes
30th Jun 202512:18 pmRNSResult of AGM
6th Jun 202511:43 amRNSPublication of Annual Report and Notice of AGM
20th May 20257:00 amRNS1st Quarter Results
30th Apr 20257:00 amRNSOperational Update for Q1 2025
25th Apr 20253:25 pmRNS2024 Report on Payments to Governments
23rd Apr 20257:00 amRNSFull Year Results
10th Apr 20253:20 pmRNSTR-1: Notification of major holdings
7th Apr 20258:41 amRNSShares Cancellation, Change in Total Voting Rights
4th Apr 20257:00 amRNSApproval of Stepnoy Leopard Field Development Plan
21st Mar 20257:00 amRNSProcessing Agreement extension with Ural Oil & Gas
6th Feb 202511:52 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSOperational Update for Q4 and FY2024
12th Dec 202412:01 pmRNSHolding(s) in Company
2nd Dec 20244:17 pmRNSPurchase and Cancellation of Deferred Shares
19th Nov 20247:00 amRNSFinancial Results for Q3 and 9M 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.